EMPOWERING MYELOMA ADVOCACY ACROSS EUROPE


LinkedIn facebook twitter youtube
News archive
Recent news

 

Myeloma Patients Europe (MPE) is holding another round of Myeloma Community Advisory Board (Myeloma-CAB) meetings from 17 – 18 November in Munich, Germany. The Myeloma-CAB focuses on providing patient perspectives and advice on clinical development in myeloma, challenges in access to myeloma medicines and patient engagement in myeloma research and development. These meeting ensure meaningful and systematic engagement with the patient community in Europe.

In preparation for this set of meetings, the members of the Myeloma-CAB received excellent training from João Carapinha on behalf of Carapinha & Company. This educational session was focused on pricing and reimbursement challenges related to myeloma.

Read here more information about Myeloma CABs.







Recent news

» Melflufen receives positive opinion from the European Medicines Agency (EMA) for the treatment of refractory myeloma

» EHA 2022 highlights in myeloma and AL amyloidosis

Leave a Reply

Your email address will not be published.

I accept the Privacy Policy